House Approves Bipartisan Bill Adding Zika To FDA’s Priority Review Voucher Qualifying Diseases List; President Obama Expected To Sign

The Hill: House approves bill to speed up Zika drugs
“The House on Tuesday overwhelmingly approved a bill to offer incentives to companies seeking cures for the Zika virus amid Congress’s growing battle over funding for the epidemic. The bipartisan legislation would add the Zika virus to a list of diseases that qualifies for a ‘priority review’ voucher from the Food and Drug Administration (FDA). It passed the Senate last month…” (Ferris, 4/12).

Reuters: Congress sends Obama bill on Zika drug development
“…White House spokeswoman Katie Hill said Obama was expected to sign the bill, which she called a ‘small step’ that could encourage the private sector to tackle Zika. ‘But it contains no funding and is ultimately insufficient on its own, since it doesn’t provide the $1.9 billion in funding that our public health experts have said is needed right now to prepare Americans for the imminent local transmission of Zika in this country,’ she said in a statement…” (Clarke, 4/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.